Syncona Portfolio Ltd
- SEC CIK
- 0001725042
- Latest filing
- Aug 6, 2026
Holdings in Q2 2023
Holdings as of Jun 30, 2023, filed Jul 27, 2023. Long positions only; changes compare share counts with Q1 2023.
- Positions
- 4
- 0 vs. Q1 2023
- Portfolio value
- $66.3M
- +$4.83M (+7.8%) vs. Q1 2023
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| AUTLAutolus Therapeutics plc | SPON ADS | 21,346,829 | $50.8M | 76.6% | 00.0% | Unchanged | History |
| Achilles Therapeutics PLC00449L102 | SPONSORED ADS | 11,086,909 | $10.5M | 15.8% | 00.0% | Unchanged | – |
| Freeline Therapeutics Hldgs35655L107 | SPONSORED ADS | 1,466,508 | $3.78M | 5.7% | −20,531,112−93.3% | Reduced | – |
| ADAPYAdaptimmune Therapeutics PLC | SPONDS ADR | 1,377,294 | $1.27M | 1.9% | 00.0% | Unchanged | History |